• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逆序概念应用于脑啡肽降解酶的完全抑制剂。

Retro-inverso concept applied to the complete inhibitors of enkephalin-degrading enzymes.

作者信息

Hernandez J F, Soleilhac J M, Roques B P, Fournié-Zaluski M C

机构信息

Département de Chimie Organique, U 266 Inserm, UA 498 CNRS, Paris, France.

出版信息

J Med Chem. 1988 Sep;31(9):1825-31. doi: 10.1021/jm00117a025.

DOI:10.1021/jm00117a025
PMID:2900898
Abstract

Peptide retro-inverso modification was applied to the complete hydroxamate inhibitors of the three zinc metallopeptidases (neutral endopeptidase 24-11 (NEP, EC 3.4.24.11), aminopeptidase N (APN, EC 3.4.11.2), and a dipeptidylaminopeptidase (DAP) involved in the in vitro enkephalin degradation by brain tissues. Compounds corresponding to the general formula RN(OH)CO(CH2)nCH(CH2Ph)NHCOCH(R')COOH (n = 0, 1) were synthesized. In the first series of inhibitors (n = 0), the "retro-inverso" modification induced a large decrease in inhibitory potency for NEP as compared to that of the parent compounds. In contrast, the presence of a methylene group between the hydroxamate and CH alpha in the second series (n = 1) led to derivatives with inhibitory potencies in the nanomolar range, similar to their analogues with a natural amide bond. On the other hand, the retro-inverso modification led to a slight improvement in the inhibition of DAP and APN, in the first series of inhibitors, while the inverse result occurred in the second series. Thus, compounds containing an alpha-amino acid moiety in P'1 position behave as weak inhibitors of the three enzymes, with IC50 values in the micromolar range, and compounds bearing a beta-amino acid moiety in the same position are more specific than the parent compounds for NEP inhibition.

摘要

肽反向修饰应用于三种锌金属肽酶(中性内肽酶24-11(NEP,EC 3.4.24.11)、氨肽酶N(APN,EC 3.4.11.2)和一种参与脑组织体外脑啡肽降解的二肽基氨肽酶(DAP))的完整异羟肟酸酯抑制剂。合成了通式为RN(OH)CO(CH2)nCH(CH2Ph)NHCOCH(R')COOH(n = 0, 1)的化合物。在第一系列抑制剂(n = 0)中,与母体化合物相比,“反向”修饰导致NEP的抑制活性大幅降低。相反,在第二系列(n = 1)中,异羟肟酸酯和α-碳之间存在亚甲基导致衍生物的抑制活性在纳摩尔范围内,与其具有天然酰胺键的类似物相似。另一方面,在第一系列抑制剂中,反向修饰导致DAP和APN的抑制作用略有改善,而在第二系列中则出现相反的结果。因此,在P'1位置含有α-氨基酸部分的化合物作为这三种酶的弱抑制剂,IC50值在微摩尔范围内,而在相同位置带有β-氨基酸部分的化合物比母体化合物对NEP的抑制更具特异性。

相似文献

1
Retro-inverso concept applied to the complete inhibitors of enkephalin-degrading enzymes.逆序概念应用于脑啡肽降解酶的完全抑制剂。
J Med Chem. 1988 Sep;31(9):1825-31. doi: 10.1021/jm00117a025.
2
Enkephalin-degrading enzyme inhibitors. Crucial role of the C-terminal residue on the inhibitory potencies of retro-hydroxamate dipeptides.脑啡肽降解酶抑制剂。C末端残基对逆羟肟酸二肽抑制效力的关键作用。
Int J Pept Protein Res. 1989 Feb;33(2):146-53. doi: 10.1111/j.1399-3011.1989.tb00200.x.
3
Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
Life Sci. 1984 Aug 27;35(9):1023-30. doi: 10.1016/0024-3205(84)90669-6.
4
New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.
J Med Chem. 1985 Sep;28(9):1158-69. doi: 10.1021/jm00147a007.
5
Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition.脑啡肽降解二肽基氨基肽酶:活性位点的表征与选择性抑制
Mol Pharmacol. 1986 Oct;30(4):338-44.
6
Inhibitors of the enkephalin degrading enzymes. Modulation of activity of hydroxamate containing compounds by modifications of the C-terminal residue.脑啡肽降解酶抑制剂。通过C端残基修饰对含异羟肟酸化合物活性的调节。
Int J Pept Protein Res. 1989 Sep;34(3):246-55. doi: 10.1111/j.1399-3011.1989.tb00237.x.
7
Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.放线菌素抑制脑啡肽降解酶时的复合效应。
Eur J Pharmacol. 1987 May 7;137(1):59-65. doi: 10.1016/0014-2999(87)90182-8.
8
Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes.
Life Sci. 1987 Jul 13;41(2):235-40. doi: 10.1016/0024-3205(87)90498-x.
9
New hydroxamate inhibitors of neurotensin-degrading enzymes. Synthesis and enzyme active-site recognition.
Int J Pept Protein Res. 1996 Aug;48(2):148-55. doi: 10.1111/j.1399-3011.1996.tb00825.x.
10
[New approach in the research of analgesics and antihypertensive agents].[镇痛药和抗高血压药研究的新方法]
Ann Pharm Fr. 1991;49(6):317-26.